A detailed history of Cidel Asset Management Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cidel Asset Management Inc holds 1,721 shares of BDX stock, worth $387,999. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,721
Previous 1,625 5.91%
Holding current value
$387,999
Previous $379,000 9.23%
% of portfolio
0.03%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$221.47 - $242.41 $21,261 - $23,271
96 Added 5.91%
1,721 $414,000
Q2 2024

Jul 19, 2024

BUY
$225.07 - $246.17 $18,230 - $19,939
81 Added 5.25%
1,625 $379,000
Q1 2024

May 08, 2024

BUY
$233.45 - $247.73 $14,940 - $15,854
64 Added 4.32%
1,544 $382,000
Q4 2023

Feb 12, 2024

BUY
$232.24 - $267.23 $343,715 - $395,500
1,480 New
1,480 $360,000
Q3 2019

Nov 12, 2019

SELL
$230.58 - $256.08 $207,522 - $230,472
-900 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$217.4 - $246.08 $145,658 - $164,873
670 Added 291.3%
900 $227,000
Q2 2019

Aug 08, 2019

SELL
$217.4 - $246.08 $139,570 - $157,983
-642 Reduced 73.62%
230 $227,000
Q1 2019

May 06, 2019

SELL
$206.05 - $248.17 $23,695 - $28,539
-115 Reduced 11.65%
872 $218,000
Q4 2018

Feb 08, 2019

BUY
$204.73 - $257.93 $23,543 - $29,661
115 Added 13.19%
987 $222,000
Q2 2018

Aug 13, 2018

SELL
$208.1 - $233.85 $17,688 - $19,877
-85 Reduced 8.88%
872 $209,000
Q1 2018

May 10, 2018

SELL
$205.46 - $240.27 $2,054 - $2,402
-10 Reduced 1.03%
957 $267,000
Q4 2017

Feb 09, 2018

SELL
$189.0 - $222.64 $17,010 - $20,037
-90 Reduced 8.51%
967 $207,000
Q3 2017

Oct 31, 2017

BUY
$186.89 - $198.9 $197,542 - $210,237
1,057
1,057 $207,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.